Prostate cancer
Mention d'édition :2nd ed. Publié par : Humana Press (Totowa, N.J. ) Détails physiques : xxi, 508 p. ill. (some col.) 27 cm. ISBN :1588296962 (alk. paper); 9781588296962 (alk. paper); 9781597452243 (eISBN); 1597452246 (eISBN).Type de document | Site actuel | Cote | Statut | Date de retour prévue | Code à barres | Réservations |
---|---|---|---|---|---|---|
Livre | La bibliothèque des Sciences Médicales et Pharmaceutiques | 616.994 63 CHU (Parcourir l'étagère) | Disponible | 0000000000487 |
Includes bibliographical references and index.
Xenograft models of human prostate cancer -- The pathology of human prostatic atrophy and inflammation -- Tissue microarrays in prostate cancer research -- Prostate (cancer) stem cells -- Cancer-host interactions: a paradigm shift brings new understanding and new opportunities -- Androgen receptor function in prostate cancer progression -- Hedgehog signaling in development and cancer -- Cholesterol, cell signaling, and prostate cancer -- Gene therapy for advanced prostate cancer -- Role of transforming growth factor- ̇in immunotherapy of prostate cancer -- Biology and therapeutic basis of prostate cancer bone metastasis -- Molecular imaging: noninvasive strategies to visualize gene expression in living subjects -- Quantum dot nanotechnology for prostate cancer research -- Expression profiling of prostate cancer progression -- Somatic alterations in prostate cancer progression -- Linkage studies of prostate cancer families to identify susceptibility genes -- Somatic DNA methylation changes and prostatic carcinogenesis -- Telomeres, telomerase, chromosome stability, and prostate cancer -- Racial differences in prostate cancer mortality -- Radiotherapy for the treatment of locally advanced prostate cancer -- Recombinant antibody candidates for treatment of prostate cancer -- Differentiation agents and epigenomic therapies: an overview and potential use for prostate cancer -- Taxane-based chemotherapy for prostate cancer -- Co-targeting therapeutics for hormone refractory prostate cancer -- Intercellular targets of prostate cancer -- Novel and efficient translational clinical trial designs in advanced prostate cancer.
Il n'y a pas de commentaire pour ce document.